GlassScriptPhysician profile
Kaveh Kousari
NPI 1407083199
$2,284.95
in general payments reported to CMS, 2019-2025
25 companies · $19.47 in 2025
The $19.47 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.00 · 2021: $649 · 2022: $808 · 2023: $594 · 2024: $159 · 2025: $19.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $518.97 | 2021-2024 | Interstim |
| Boston Scientific Corporation | $252.82 | 2021-2023 | Lithovue, Solyx Sis System |
| Myriad Genetic Laboratories, INC. | $213.80 | 2021-2025 | Prolaris |
| Olympus America INC. | $166.48 | 2022-2023 | Olympus, Uretero-Reno Videoscope |
| Axonics, INC. | $121.07 | 2022-2023 | Axonics, Bulkamid |
| Photocure INC | $117.23 | 2021-2023 | Cysview |
| Astellas Pharma US INC | $110.33 | 2019-2024 | Xtandi |
| Procept Biorobotics Corporation | $107.55 | 2021 | |
| Abbvie INC. | $101.11 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $97.94 | 2023-2024 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $74.21 | 2021-2023 | Lynparza, Keytruda |
| Myovant Sciences INC. | $71.22 | 2021-2022 | |
| Teleflex LLC | $45.69 | 2023 | Urolift |
| Janssen Biotech, INC. | $40.88 | 2021 | |
| Davol INC. | $35.51 | 2023 | Arista Ah Flexitip |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $35.06 | 2022-2023 | Illuccix |
| Foundation Medicine, INC. | $28.10 | 2021 | |
| Laborie Medical Technologies Corp. | $24.46 | 2023 | |
| Hollister Incorporated | $22.53 | 2023 | Infyna Chic |
| 180 Medical, INC. | $21.25 | 2023 | |
| Pfizer INC. | $17.38 | 2024 | |
| Calyxo, INC. | $16.73 | 2024 | Cvac Aspiration System |
| Cook Medical LLC | $15.27 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.00 | 2021 | |
| Urovant Sciences INC | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaveh Kousari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.